HbA1c levels measured by enzymatic assay during off-site health checkups are lower than those measured by on-site HPLC assay.

Enzymatic assay HPLC assay HbA1c Health checkup

Journal

Diabetology international
ISSN: 2190-1678
Titre abrégé: Diabetol Int
Pays: Japan
ID NLM: 101553224

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 27 06 2019
accepted: 13 08 2019
entrez: 18 1 2020
pubmed: 18 1 2020
medline: 18 1 2020
Statut: epublish

Résumé

HbA1c is widely used as a therapeutic target marker and as a diagnostic marker for diabetes mellitus. This has led to an increasing frequency of HbA1c measurements in current health checkups throughout Japan. In the present study, we compared the HbA1c levels measured by an enzymatic assay (EA-HbA1c) off-site during health checkups with the HbA1c levels measured by on-site ion-exchange high-performance liquid chromatography (HPLC; HPLC-HbA1c) in a hospital. A total of 96 individuals (53 males and 43 females; age, 68.9 ± 8.4 years old; 70 diabetic and 26 non-diabetic individuals) whose HbA1c levels were measured by both the methods listed above were included in the study. Since no HPLC-HbA1c levels were measured on the day of the health checkup, HPLC-HbA1c levels were estimated using HPLC-HbA1c levels measured before and after the health checkup. A significant correlation of HbA1c levels was observed between the two groups (

Identifiants

pubmed: 31950005
doi: 10.1007/s13340-019-00407-8
pii: 407
pmc: PMC6942106
doi:

Types de publication

Journal Article

Langues

eng

Pagination

67-71

Informations de copyright

© The Japan Diabetes Society 2019.

Déclaration de conflit d'intérêts

Conflict of interestThe authors declare that they have no conflicts of interest.

Références

Diabetes Care. 2003 Jan;26(1):163-7
pubmed: 12502674
Diabetes Care. 2019 Jan;42(Suppl 1):S61-S70
pubmed: 30559232
Ann Clin Biochem. 2017 Jul;54(4):432-437
pubmed: 27496792
Clin Chem. 1989 Jun;35(6):958-62
pubmed: 2731368
Cardiovasc Diabetol. 2015 Jun 24;14:84
pubmed: 26099223
Cardiovasc Diabetol. 2014 Feb 17;13:45
pubmed: 24533962
J Diabetes Sci Technol. 2015 Mar;9(2):200-5
pubmed: 25633966
Diabetol Int. 2016 Mar 9;7(4):391-397
pubmed: 30603291

Auteurs

Masafumi Koga (M)

Department of Internal Medicine, Hakuhokai Central Hospital, 4-23-1 Higashisonodacho, Amagasaki, Hyogo 661-0953 Japan.
Department of Internal Medicine, Kawanishi City Hospital, Kawanishi, Hyogo Japan.

Mari Okuda (M)

Department of Nursing, Kawanishi City Hospital, Kawanishi, Hyogo Japan.

Shinya Inada (S)

Department of Internal Medicine, Kawanishi City Hospital, Kawanishi, Hyogo Japan.

Shin-Ichiro Ueda (SI)

Department of Internal Medicine, Kawanishi City Hospital, Kawanishi, Hyogo Japan.

Yuko Nakamura (Y)

Department of Internal Medicine, Kawanishi City Hospital, Kawanishi, Hyogo Japan.

Toshika Okumiya (T)

4Department of Biomedical Laboratory Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Midori Ishibashi (M)

5Department of Clinical Laboratory, New Tokyo Hospital, Matsudo, Chiba Japan.

Classifications MeSH